Author

Rony Dahan

Weizmann Institute of ScienceORCID 0000-0002-8420-7601Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

Arturo Simoni NievesiD· 2 shared Boobash-Raj Selvadurai· 2 shared Deepthi Ramesh-KumariD· 2 shared Moshit LindzeniD· 2 shared Nitin Gupta· 2 shared Rishita ChatterjeeiD· 2 shared Suvendu GiriiD· 2 shared Yahel AvrahamiD· 2 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Arturo Simoni NievesORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Computational design of structurally diverse antibody repertoires with drug-like properties

Ariel Tennenhouse, Rebecca E Wilen, Sveta Gaiduk, Roman Kamyshinsky, Sarah Borni, Mazal Faraj, Eliane Hadas Yardeni, Moshe Goldsmith, Inbar Cahana, Shira Albeck, Tamar Unger, Rony Dahan, Ron Diskin, Sarel Jacob Fleishman

The paper designs structurally diverse antibody repertoires with drug-like properties using a computational method called CADAbRe, demonstrating their utility in binding to challenging targets.

bioRxiv · Jul 13, 2026 · PreprintSynthetic Biology

Co-targeting MERTK and EGFR with a Bispecific Antibody Overcomes Drug Resistance Across Mutations in Exons 19, 20, and 21

Suvendu Giri, Boobash-Raj Selvadurai, Arturo Simoni Nieves, Nitin Gupta, Moshit Lindzen, Rishita Chatterjee, Alessandro Genna, Marieke Van Daele, Deepthi Ramesh-Kumar, Mirie Zerbib, Roni Oren, Isabelle Sophie Meijer, Elisabeth Franziska Wippich, Yahel Avraham, Rony Dahan, , Yosef Yarden

This study develops a bispecific antibody targeting MERTK and EGFR to overcome drug resistance in lung cancer with mutations in exons 19, 20, and 21.

bioRxiv · Oct 16, 2025 · PreprintCancer Biology

Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored Immunotherapy

Rishita Chatterjee, Arturo Simoni Nieves, An Nhien Truong, Moshit Lindzen, Furkan Ozmen, Christopher Cherry, Pascale Zwicky, Saptaparna Mukherjee, Boobash-Raj Selvadurai, Tomer Meir Salame, Nitin Gupta, Suvendu Giri, Lior Kramarski, Yahel Avraham, Eviatar Weizman, , Yosef Yarden

This study identifies a p53 mutation-specific immunotherapy strategy for ovarian cancer by targeting AREG and PD-L1, showing efficacy in mouse models and patient-derived organoids.

bioRxiv · Jun 23, 2025 · PreprintCancer Biology